Statistical methods have rarely been applied to learn individualized treatment rules, or rules for altering treatments over time in response to changes in individual covariates. Termed dynamic treatment regimes in the statistical literature, such individualized treatment rules are of primary importance in the practice of clinical medicine. History-Adjusted Marginal Structural Models (HA-MSM) estimate individualized treatment rules that assign, at each time point, the first action of the future static treatment plan that optimizes expected outcome given a patient\u27s covariates. However, as we discuss here, the optimality of these rules can depend on the way in which treatment was assigned in the data from which the rules were derived. In t...
Dynamic treatment regimes are set rules for sequential decision making based on patient covariate hi...
Much of epidemiology and clinical medicine is focused on the estimation of treatments or interventio...
We study the design of multi-armed parallel group clinical trials to estimate personalized treatment...
Individualized treatment rules, or rules for altering treatments over time in response to changes in...
Consider a longitudinal observational or controlled study in which one collects chronological data o...
Much of clinical medicine involves choosing a future treatment plan that is expected to optimize a p...
Marginal structural models (MSM) provide a powerful tool for estimating the causal effect of a treat...
Treatment rules based on individual patient characteristics that are easy to interpret and dissemina...
In this paper, we argue that causal effect models for realistic individualized treatment rules repre...
Estimation and evaluation of individualized treatment rules have been studied extensively, but real-...
Multistate process data are common in studies of chronic diseases such as cancer. These data are ide...
Dynamic treatment regimes (DTRs) are sequential decision rules for individual patients that can adap...
Dynamic treatment regimes are set rules for sequential decision making based on patient covariate hi...
This paper studies statistical decisions for dynamic treatment assignment problems. Many policies in...
There is increasing interest in discovering individualized treatment rules for patients who have het...
Dynamic treatment regimes are set rules for sequential decision making based on patient covariate hi...
Much of epidemiology and clinical medicine is focused on the estimation of treatments or interventio...
We study the design of multi-armed parallel group clinical trials to estimate personalized treatment...
Individualized treatment rules, or rules for altering treatments over time in response to changes in...
Consider a longitudinal observational or controlled study in which one collects chronological data o...
Much of clinical medicine involves choosing a future treatment plan that is expected to optimize a p...
Marginal structural models (MSM) provide a powerful tool for estimating the causal effect of a treat...
Treatment rules based on individual patient characteristics that are easy to interpret and dissemina...
In this paper, we argue that causal effect models for realistic individualized treatment rules repre...
Estimation and evaluation of individualized treatment rules have been studied extensively, but real-...
Multistate process data are common in studies of chronic diseases such as cancer. These data are ide...
Dynamic treatment regimes (DTRs) are sequential decision rules for individual patients that can adap...
Dynamic treatment regimes are set rules for sequential decision making based on patient covariate hi...
This paper studies statistical decisions for dynamic treatment assignment problems. Many policies in...
There is increasing interest in discovering individualized treatment rules for patients who have het...
Dynamic treatment regimes are set rules for sequential decision making based on patient covariate hi...
Much of epidemiology and clinical medicine is focused on the estimation of treatments or interventio...
We study the design of multi-armed parallel group clinical trials to estimate personalized treatment...